WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 4'5801 Infant (under 12 months) mortality rate: 962
GDP / capita (US$): 6'1051 Child (under 5 years) mortality rate: 1582

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 20'821  20'180  19'549  18'927  18'314  13'925  10'334  7'637 
Births 934  920  906  891  875  709  548  405 
Surviving infants 844  829  815  800  785  619  465  341 
Pop. less than 5 years 3'966  3'895  3'796  3'705  3'609  2'731  2'055  1'491 
Pop. less than 15 years 9'930  9'647  9'346  9'070  8'786  6'633  4'905  3'550 
Female 15-49 years 4'627  4'477  4'339  4'194  4'057  3'112  2'287  1'705 

Number of reported case

(Click for retrospective incidence data for Angola)
Diphtheria 15  69  64 
Japanese encephalitis
Measles 4'458  1'449  1'190  2'807  265  2'219  29'069  29'656 
Mumps
Pertussis 1'259  1'554  2'539  1'127  1'148  560  14'420  54'126 
Polio* 33  29  29  115  32 
Rubella 65  24  38  10  28 
Rubella (CRS)
Tetanus (neonatal) 75  13  66  89  131  959  541 
Tetanus (total) 543  953  490  675  601  1'826  1'185 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Angola)
Vaccine year result method % card seen                                                
BCG 2000  69  MICS   34.1  87  88  93  83  87  56 
DTP1 2000  56  MICS   34.1  99*  99*  99*  93  100  44 
DTP3 2000  34  MICS   34.1  91  86  91  73  81  31 
HepB_BD         
HepB3          91  86  91  73  81 
Hib3          91  86  91  73  81 
JapEnc         
MCV 2000  53  MICS   34.1  97  88  93  77  79 
MCV2         
PCV1         
PCV3         
Pol3 2000  63  MICS   34.1  88  85  92  73  75  33 
Rota1         
Rota_last         
Rubella1         
TT2plus 2000  62  MICS   34.1  78  79  87  77  82 
PAB         
VAD1          21  18  19  14  20 
YFV          63  64  40  40  61  29 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Angola)
BCG 87  88  93  83  87  56  48 
DTP1 99  99  99  93  99  44  48 
DTP3 91  86  91  73  81  31  24 
HepB3 91  86  91  73  81 
Hib3 91  86  91  73  81 
MCV 97  88  93  77  79  41  38 
PAB 72  70  75  88  79  60  34 
PCV3
Pol3 88  85  92  73  75  33  23 
Rota_last
YFV 63  64  40  40  61  50 

Number of districts in the country 165  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 58
From 80 to 89% 10
From 50 to 79% 21
Less than 50% 12
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 2, 4, 6 months; Yes
Measles 9 months; Yes
OPV Birth; 2, 4, 6 months; Yes
Pneumo_conj 2, 4, 6 months; Yes From April 2013
Rotavirus 2, 4 months; From April 2014
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 9 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 
What years does the MYP cover? number 2011-2015  2011-2015  2011- 2015  2010-2015  2009 - 2012  2009-2012  NA 
Nº of districts with microplans that include activities to raise immunization coverage number 123  120  79    160  160  164 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  No         

System performance

Total number of districts in country number 165  164  164  164  164  164  164 
Nº districts with DTP3 coverage >=80% number 112  96  99  65  76  89 
% of districts with DTP3 coverage >=80% From 0 to 100% 68  59  60  40  46  54 
Nº districts with measles (MCV1) coverage >=95% number 87  74  81  53  53     
% of districts with MCV1 coverage >=95% From 0 to 100% 53  45  49  32  32     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR No  No  No  No  Yes  No  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100    29  100    18  67 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No No  No  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.